Innovative Egg Assessment Tool From Canadian Med-Tech Startup Future Fertility Has Been Adopted For Patient Use by Trio Fertility

August 11, 2020

TORONTO, Aug. 11, 2020 /PRNewswire/ – Canadian startup company Future Fertility has commercially launched a product that is providing a new solution in the field of Assisted Reproductive Technology (ART). Their newly marketed product Violet™ is a cloud-based software that assesses the probability of an oocyte (human egg) to successfully fertilize and reach a blastocyst embryo stage. Violet™, an AI-based image technology that has been optimized through scientific collaborations with several In-Vitro Fertilization (IVF) clinics around the world, analyzes 2-D images of a patient’s eggs in real-time. Until now, there has been no accepted method to visually grade an egg or predict its reproductive potential.

> Continue reading

Related posts

October 05, 2020

Graduate Student Research Internship

Canadian med-tech startup Future Fertility is looking for a graduate student for a 3-6 month internship starting immediately. At [...]
January 08, 2021

Women May Soon Start Using AI to Tell Good Eggs From Bad

Future Fertility, the first company to use artificial intelligence to grade the viability of women’s harvested eggs for use in [...]
April 30, 2019

Future Fertility Launches First AI Image Analysis Tool to Evaluate Women’s Eggs

TORONTO, April 30, 2019 /CNW/ — Future Fertility Inc, an AI biotech startup focusing on reproductive innovation has developed a non-invasive image [...]